Milan Lukas

Milan Lukas

Prague, PR, Czech Republic

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 84 publications

Persistence of advanced therapies in patients with ulcerative colitis: real-world data from the nationwide CREdIT registry.

Persistence of advanced therapies in patients with ulcerative colitis: real-world data from the nationwide CREdIT registry.

Journal: Therapeutic advances in gastroenterology

Published: November 18, 2025

Sequencing JAK-inhibitors in ulcerative colitis: effectiveness and safety of switching within treatment class.

Sequencing JAK-inhibitors in ulcerative colitis: effectiveness and safety of switching within treatment class.

Journal: Journal of Crohn's & colitis

Published: November 03, 2025

Sequencing JAK-inhibitors in ulcerative colitis: effectiveness and safety of switching within treatment class.

Sequencing JAK-inhibitors in ulcerative colitis: effectiveness and safety of switching within treatment class.

Journal: Journal of Crohn's & colitis

Published: November 03, 2025

Mirikizumab in ulcerative colitis: real-world evidence from an international two-center retrospective cohort study.

Mirikizumab in ulcerative colitis: real-world evidence from an international two-center retrospective cohort study.

Journal: Therapeutic advances in gastroenterology

Published: August 01, 2025

Final results from the vedolizumab extended access program multinational study demonstrate long-term treatment persistence and safety.

Final results from the vedolizumab extended access program multinational study demonstrate long-term treatment persistence and safety.

Journal: Therapeutic advances in gastroenterology

Published: July 29, 2025

The effectiveness of second- and-third-line biologics in perianal Crohn's disease-a multicenter propensity score-matched study.

The effectiveness of second- and-third-line biologics in perianal Crohn's disease-a multicenter propensity score-matched study.

Journal: Journal of Crohn's & colitis

Published: June 10, 2025

Second-line strategies after anti-TNF failure in chronically active, moderate-to-severe ulcerative colitis: a retrospective, multicentre cohort study.

Second-line strategies after anti-TNF failure in chronically active, moderate-to-severe ulcerative colitis: a retrospective, multicentre cohort study.

Journal: Expert opinion on biological therapy

Published: May 10, 2025

Janus Kinase Inhibitor-Induced Acne in Inflammatory Bowel Disease: An International, Multicenter, Retrospective Cohort Study.

Janus Kinase Inhibitor-Induced Acne in Inflammatory Bowel Disease: An International, Multicenter, Retrospective Cohort Study.

Journal: Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association

Published: March 30, 2025

Response.

Response.

Journal: Gastrointestinal endoscopy

Published: March 27, 2025

Effect of tofacitinib exposure in utero and during breastfeeding on the immune status of exposed child.

Effect of tofacitinib exposure in utero and during breastfeeding on the immune status of exposed child.

Journal: Journal of Crohn's & colitis

Published: March 24, 2025

Comparative Effectiveness of Tofacitinib vs Upadacitinib for the Treatment of Acute Severe Ulcerative Colitis.

Comparative Effectiveness of Tofacitinib vs Upadacitinib for the Treatment of Acute Severe Ulcerative Colitis.

Journal: Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association

Published: January 15, 2025

Real-World Effectiveness and Safety of Selective JAK Inhibitors in Ulcerative Colitis and Crohn's Disease: A Retrospective, Multicentre Study.

Real-World Effectiveness and Safety of Selective JAK Inhibitors in Ulcerative Colitis and Crohn's Disease: A Retrospective, Multicentre Study.

Journal: Journal of clinical medicine

Published: November 14, 2024

Showing 1-12 of 84

Last Updated: 09/26/2026